1
|
Galluccio T, Cerretti R, Guagnano A, Troiano M, Andreani M. Identification of the novel HLA-DPA1*01:130 allele by next-generation sequencing. HLA 2024; 103:e15236. [PMID: 37750458 DOI: 10.1111/tan.15236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Revised: 09/13/2023] [Accepted: 09/15/2023] [Indexed: 09/27/2023]
Abstract
The novel HLA-DPA1*01:130 allele differs from HLA-DPA1*01:03:01:03 by one nucleotide substitution in Exon 3.
Collapse
Affiliation(s)
- T Galluccio
- Laboratory of Immunogenetics and Transplant, Department of Oncohematology and Cell and Gene Therapy, IRCCS Bambin Gesù Pediatric Hospital, Rome, Italy
| | - R Cerretti
- Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy
- Rome Transplant Network, Tor Vergata University Hospital, Rome, Italy
| | - A Guagnano
- Laboratory of Immunogenetics and Transplant, Department of Oncohematology and Cell and Gene Therapy, IRCCS Bambin Gesù Pediatric Hospital, Rome, Italy
| | - M Troiano
- Laboratory of Immunogenetics and Transplant, Department of Oncohematology and Cell and Gene Therapy, IRCCS Bambin Gesù Pediatric Hospital, Rome, Italy
| | - M Andreani
- Laboratory of Immunogenetics and Transplant, Department of Oncohematology and Cell and Gene Therapy, IRCCS Bambin Gesù Pediatric Hospital, Rome, Italy
| |
Collapse
|
2
|
Troiano M, Giustiniani P, Pinto RM, Di Luzio A, Andreani M. The new HLA-DQB1*05:304 allele identified in an Italian patient. HLA 2023; 102:540-541. [PMID: 37503843 DOI: 10.1111/tan.15167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 07/13/2023] [Accepted: 07/18/2023] [Indexed: 07/29/2023]
Abstract
DQB1*05:304 allele was identical to DQB1*05:02:01 except for a single nucleotide substitution.
Collapse
Affiliation(s)
- M Troiano
- Department of Oncohematology and Cell and Gene Therapy, Laboratory of Immunogenetics of Transplant, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy
| | - P Giustiniani
- Department of Oncohematology and Cell and Gene Therapy, Laboratory of Immunogenetics of Transplant, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy
| | - R M Pinto
- Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy
| | - A Di Luzio
- Department of Oncohematology and Cell and Gene Therapy, Laboratory of Immunogenetics of Transplant, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy
| | - M Andreani
- Department of Oncohematology and Cell and Gene Therapy, Laboratory of Immunogenetics of Transplant, IRCCS Bambino Gesù Pediatric Hospital, Rome, Italy
| |
Collapse
|
3
|
Bonan P, Fusco I, Bruscino N, Madeddu F, Troiano M, Verdelli A, Piccolo D, Rampino G. Laser-assisted blepharoplasty: An innovative safe and effective technique. Skin Res Technol 2023; 29:e13351. [PMID: 37231919 PMCID: PMC10189347 DOI: 10.1111/srt.13351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Accepted: 05/04/2023] [Indexed: 05/27/2023]
Abstract
BACKGROUND Blepharoplasty is one of the most popular esthetic procedures with an acceptable risk profile and a relatively quick procedure. METHODS The aim was to evaluate the efficacy and safety of a new CO2 and 1540-nm laser-assisted blepharoplasty technique applied to the upper and lower eyelids. A total of 38 patients were enrolled. Photographs were taken before the treatment and at 6-month follow-up. One "blind" observer assessed the performance of this technique by ranking the results in four categories of eyelid esthetic: 1 = no or poor results (0%-25%), 2 = slight improvement (25%-50%), 3 = moderate improvement (50%-75%) and 4 = marked improvement (75%-100%). All possible complications were monitored. RESULTS Thirty-two patients (84 %) achieved marked improvement, four patients (11%) moderate improvement, two patients (5 %) slight improvement, while zero subjects (0%) poor or no improvement. No serious adverse effects were observed. CONCLUSIONS Our results from clinical evaluations suggest that the CO2 and 1540-nm laser assisted blepharoplasty is proved to be a sophisticate intervention efficacious in improving the treatment of patients with various degrees of eyelid and periocular aging and also in reducing downtime.
Collapse
Affiliation(s)
- Paolo Bonan
- Laser Cutaneous Cosmetic and Plastic Surgery UnitVilla Donatello ClinicFlorenceItaly
| | | | - Nicola Bruscino
- Laser Cutaneous Cosmetic and Plastic Surgery UnitVilla Donatello ClinicFlorenceItaly
| | | | - Michela Troiano
- Laser Cutaneous Cosmetic and Plastic Surgery UnitVilla Donatello ClinicFlorenceItaly
| | - Alice Verdelli
- Laser Cutaneous Cosmetic and Plastic Surgery UnitVilla Donatello ClinicFlorenceItaly
| | - Domenico Piccolo
- Skin Center – Dermal‐Aesthetic Laser Centres, Avezzano, Pescara and L'AquilaPescaraItaly
| | - Giuseppe Rampino
- Laser Cutaneous Cosmetic and Plastic Surgery UnitVilla Donatello ClinicFlorenceItaly
| |
Collapse
|
4
|
Babore Y, Li X, Clark T, Troiano M, Peacock A, Mantell M, Vance A. Abstract No. 205 Safety and Effectiveness of Concurrent Below- and Above-the-Ankle Intervention in Patients with Critical Limb Ischemia. J Vasc Interv Radiol 2023. [DOI: 10.1016/j.jvir.2022.12.264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2023] Open
|
5
|
Babore Y, Vance A, Cohean R, Mantell M, Troiano M, Peacock A, Reddy S, Clark T. Abstract No. 33 End-Stage Renal Disease and Risk of Major Adverse Limb Events Following Peripheral Vascular Intervention. J Vasc Interv Radiol 2023. [DOI: 10.1016/j.jvir.2022.12.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/26/2023] Open
|
6
|
Bonan P, Troiano M, Bruscino N, Verdelli A. Treatment of benign hyperpigmentations and pigmented scars by 755 alexandrite laser comparing the Single Pass versus MultiPass (MoveoPL) emission in skin types I-IV. Dermatol Ther 2021; 34:e14819. [PMID: 33506629 DOI: 10.1111/dth.14819] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2020] [Accepted: 12/26/2020] [Indexed: 11/28/2022]
Abstract
Lasers are effective treatments for benign hyperpigmentations but may be difficult especially in darker skin type. In this randomized split-face controlled study on benign hyperpigmentations and pigmented scars, we compare the standard Single Pass (SP) emission with the MultiPass emission (MoveoPL) 755 alexandrite laser. Patients, skin types I-IV, with solar lentigines and ephelides of the face, chest, and hands and patients with pigmented scars of the legs, underwent laser treatment, by treating one side of the body or half scar using the SP and the other side using MoveoPL. Improvements according to a grading score system, side effects, and patient satisfaction were recorded. About 63 patients were enrolled. An overall improvement of benign hyperpigmentations and pigmented scars was recorded, with a grading score (±SD) of 2.8 ± 0.8 for SP and 3.6 ± 0.5 for MoveoPL (range, 0-4). SP emission showed best results in skin types I-II whereas MotusPL obtained successfully results in all the phototypes analyzed (types I-IV). Patients preferred MoveoPL as it was associated with fewer side effects. Both standard SP and MoveoPL emission are effective and safe. MoveoPL showed a higher efficacy and safety profile for the treatment of hyperpigmentations.
Collapse
Affiliation(s)
- Paolo Bonan
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| | - Michela Troiano
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| | - Nicola Bruscino
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| | - Alice Verdelli
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| |
Collapse
|
7
|
Bonan P, Troiano M, Verdelli A. Safety and efficacy of single pass vs
multipass
emission with 755 alexandrite laser for
all‐skin‐type
hair removal: A pilot study. Dermatol Ther 2020; 33:e14001. [DOI: 10.1111/dth.14001] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2020] [Accepted: 06/23/2020] [Indexed: 12/01/2022]
Affiliation(s)
- Paolo Bonan
- Laser Cutaneous Cosmetic & Plastic Surgery Unit Villa Donatello Clinic Florence Italy
| | - Michela Troiano
- Laser Cutaneous Cosmetic & Plastic Surgery Unit Villa Donatello Clinic Florence Italy
| | - Alice Verdelli
- Laser Cutaneous Cosmetic & Plastic Surgery Unit Villa Donatello Clinic Florence Italy
| |
Collapse
|
8
|
Bonan P, Bassi A, Bruscino N, Schincaglia E, Gavrilova M, Troiano M, Verdelli A. Combined pulsed dye laser and Q-switched Nd:YAG laser intraumatic facial tattoo removal: A case series. Dermatol Ther 2019; 32:e13069. [PMID: 31430015 DOI: 10.1111/dth.13069] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2019] [Accepted: 08/15/2019] [Indexed: 11/29/2022]
Abstract
Traumatic tattoos can be treated with several methods, including mechanical and chemical devices. However, they are rarely used due to the high risk of permanent side effects such as scarring and depigmentation. Recently, laser devices, especially the Q-switched (QS) laser and the pulsed dye laser (PDL), applied in combination, have achieved complete clearance of the lesions without any risk of side effects. Herein, we reported three cases of traumatic facial tattoos successfully treated with combined PDL and QS Nd:YAG laser.
Collapse
Affiliation(s)
- Paolo Bonan
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| | - Andrea Bassi
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| | - Nicola Bruscino
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| | - Emiliano Schincaglia
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| | - Maria Gavrilova
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| | - Michela Troiano
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| | - Alice Verdelli
- Laser Cutaneous Cosmetic & Plastic Surgery Unit, Villa Donatello Clinic, Florence, Italy
| |
Collapse
|
9
|
Farina G, Iaccarino S, Troiano M, Iovine M, Vigliotti M, Attingenti E, Camera A, Frigeri F. THE ADDITION AT DAY 9 OF HD-MTX TO THE (DA)-EPOCH SCHEME WITH OR WITHOUT RITUXIMAB IS AN EFFECTIVE REGIMEN IN UNTREATED ADVANCED STAGE HIGH RISK LYMPHOMA: A FEASIBILITY STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.117_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- G. Farina
- Hematology-Oncology Unit; AORN "Sant'Anna e San Sebastiano"; Caserta Italy
| | - S. Iaccarino
- Hematology-Oncology Unit; AORN "Sant'Anna e San Sebastiano"; Caserta Italy
| | - M. Troiano
- Hematology-Oncology Unit; AORN "Sant'Anna e San Sebastiano"; Caserta Italy
| | - M. Iovine
- Hematology-Oncology Unit; AORN "Sant'Anna e San Sebastiano"; Caserta Italy
| | - M. Vigliotti
- Hematology-Oncology Unit; AORN "Sant'Anna e San Sebastiano"; Caserta Italy
| | - E. Attingenti
- Hematology-Oncology Unit; AORN "Sant'Anna e San Sebastiano"; Caserta Italy
| | - A. Camera
- Hematology-Oncology Unit; AORN "Sant'Anna e San Sebastiano"; Caserta Italy
| | - F. Frigeri
- Hematology-Oncology Unit; AORN "Sant'Anna e San Sebastiano"; Caserta Italy
| |
Collapse
|
10
|
Troiano M, Bagnoli A, Nante N, Troiano G. A political, sociological and medical analysis of “Operation Sophia”. Eur J Public Health 2017. [DOI: 10.1093/eurpub/ckx186.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - A Bagnoli
- Public Nutrition and Hygiene Unit, USL Toscana Sud Est, Siena, Italy
| | - N Nante
- Post Graduate School of Public Health, University of Siena, Siena, Italy
| | - G Troiano
- Post Graduate School of Public Health, University of Siena, Siena, Italy
| |
Collapse
|
11
|
Condello R, Picardi A, Battarra M, Troiano M, Andreani M. Identification of the novel allele, HLA-A*02:653, in an Italian patient. HLA 2017; 90:300-301. [PMID: 28786538 DOI: 10.1111/tan.13112] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2017] [Revised: 08/01/2017] [Accepted: 08/02/2017] [Indexed: 11/30/2022]
Abstract
HLA-A*02:653 differs from A*02:01:01:01 by a C to T substitution in exon 2.
Collapse
Affiliation(s)
- R Condello
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation at Polyclinic of Tor Vergata, Rome, Italy
| | - A Picardi
- Department of Biomedicine and Prevention, Hematology Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy
| | - M Battarra
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation at Polyclinic of Tor Vergata, Rome, Italy
| | - M Troiano
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation at Polyclinic of Tor Vergata, Rome, Italy
| | - M Andreani
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation at Polyclinic of Tor Vergata, Rome, Italy
| |
Collapse
|
12
|
Testi M, Battarra M, Catalano M, Troiano M, Andreani M. Characterization of the novel HLA-C*02:106 allele in a hematopoietic stem cell volunteer donor. HLA 2016; 88:52-3. [PMID: 27283262 DOI: 10.1111/tan.12826] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Revised: 05/04/2016] [Accepted: 05/09/2016] [Indexed: 11/29/2022]
Abstract
HLA-C*02:106 allele differs from C*02:02:02:01 by a C to T substitution in exon 4.
Collapse
Affiliation(s)
- M Testi
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation, Tor Vergata University Hospital, Rome, Italy.,Medical Genetics Lab, Sapienza University, San Camillo-Forlanini Hospital, Rome, Italy
| | - M Battarra
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation, Tor Vergata University Hospital, Rome, Italy
| | - M Catalano
- Medical Genetics Lab, Sapienza University, San Camillo-Forlanini Hospital, Rome, Italy
| | - M Troiano
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation, Tor Vergata University Hospital, Rome, Italy
| | - M Andreani
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation, Tor Vergata University Hospital, Rome, Italy
| |
Collapse
|
13
|
Testi M, Troiano M, Paladini E, Di Luzio A, Andreani M. A nucleotide insertion in Exon 2 is responsible for a new HLA-DRB1 null allele,HLA-DRB1*14:166N. HLA 2015; 87:60. [DOI: 10.1111/tan.12705] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2015] [Accepted: 10/23/2015] [Indexed: 11/28/2022]
Affiliation(s)
- M. Testi
- IME Foundation at Polyclinic of Tor Vergata; Laboratory of Immunogenetics and Transplant Biology; Rome Italy
| | - M. Troiano
- IME Foundation at Polyclinic of Tor Vergata; Laboratory of Immunogenetics and Transplant Biology; Rome Italy
| | - E. Paladini
- IME Foundation at Polyclinic of Tor Vergata; Laboratory of Immunogenetics and Transplant Biology; Rome Italy
| | - A. Di Luzio
- IME Foundation at Polyclinic of Tor Vergata; Laboratory of Immunogenetics and Transplant Biology; Rome Italy
| | - M. Andreani
- IME Foundation at Polyclinic of Tor Vergata; Laboratory of Immunogenetics and Transplant Biology; Rome Italy
| |
Collapse
|
14
|
Cicchi R, Kapsokalyvas D, Troiano M, Campolmi P, Morini C, Massi D, Cannarozzo G, Lotti T, Pavone FS. In vivo non-invasive monitoring of collagen remodelling by two-photon microscopy after micro-ablative fractional laser resurfacing. J Biophotonics 2014. [PMID: 24339127 DOI: 10.1002/jbio.v7.11/12] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Non-linear optical microscopy is becoming popular as a non-invasive in vivo imaging modality in dermatology. In this study, combined TPF and SHG microscopy were used to monitor collagen remodelling in vivo after micro-ablative fractional laser resurfacing. Papillary dermis of living subjects, covering a wide age range, was imaged immediately before and forty days after treatment. A qualitative visual examination of acquired images demonstrated an age-dependent remodelling effect on collagen. Additional quantitative analysis of new collagen production was performed by means of two image analysis methods. A higher increase in SHG to TPF ratio, corresponding to a stronger treatment effectiveness, was found in older subjects, whereas the effect was found to be negligible in young, and minimal in middle age subjects. Analysis of collagen images also showed a dependence of the treatment effectiveness with age but with controversial results. While the diagnostic potential of in vivo multiphoton microscopy has already been demonstrated for skin cancer and other skin diseases, here we first successfully explore its potential use for a non-invasive follow-up of a laser-based treatment.
Collapse
Affiliation(s)
- Riccardo Cicchi
- National Institute of Optics, National Research Council INO-CNR, Largo E. Fermi 6, 50125, Florence, Italy; European Laboratory for Non-linear Spectroscopy LENS, Via Nello Carrara 1, 50019, Sesto Fiorentino, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Cicchi R, Kapsokalyvas D, Troiano M, Campolmi P, Morini C, Massi D, Cannarozzo G, Lotti T, Pavone FS. In vivo non-invasive monitoring of collagen remodelling by two-photon microscopy after micro-ablative fractional laser resurfacing. J Biophotonics 2014; 7:914-925. [PMID: 24339127 DOI: 10.1002/jbio.201300124] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/08/2013] [Revised: 10/02/2013] [Accepted: 11/12/2013] [Indexed: 06/03/2023]
Abstract
Non-linear optical microscopy is becoming popular as a non-invasive in vivo imaging modality in dermatology. In this study, combined TPF and SHG microscopy were used to monitor collagen remodelling in vivo after micro-ablative fractional laser resurfacing. Papillary dermis of living subjects, covering a wide age range, was imaged immediately before and forty days after treatment. A qualitative visual examination of acquired images demonstrated an age-dependent remodelling effect on collagen. Additional quantitative analysis of new collagen production was performed by means of two image analysis methods. A higher increase in SHG to TPF ratio, corresponding to a stronger treatment effectiveness, was found in older subjects, whereas the effect was found to be negligible in young, and minimal in middle age subjects. Analysis of collagen images also showed a dependence of the treatment effectiveness with age but with controversial results. While the diagnostic potential of in vivo multiphoton microscopy has already been demonstrated for skin cancer and other skin diseases, here we first successfully explore its potential use for a non-invasive follow-up of a laser-based treatment.
Collapse
Affiliation(s)
- Riccardo Cicchi
- National Institute of Optics, National Research Council INO-CNR, Largo E. Fermi 6, 50125, Florence, Italy; European Laboratory for Non-linear Spectroscopy LENS, Via Nello Carrara 1, 50019, Sesto Fiorentino, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Davids MR, Marais N, Jacobs J, Cohen E, Krause I, Goldberg E, Garty M, Krause I, Dursun B, Sahan Y, Tanriverdi H, Rota S, Uslu S, Senol H, Minutolo R, Gabbai FB, Agarwal R, Chiodini P, Borrelli S, Stanzione G, Nappi F, Bellizzi V, Conte G, De Nicola L, Van De Walle J, Johnson S, Fremeaux-Bacchi V, Ardissino G, Ariceta G, Beauchamp J, Cohen D, Greenbaum LA, Ogawa M, Schaefer F, Licht C, Scalzotto E, Nalesso F, Zaglia T, Corradi V, Neri M, Martino F, Zanella M, Brendolan A, Mongillo M, Ronco C, Chinnappa S, Mooney A, El Nahas AM, Tu YK, Tan LB, Jung JY, Kim AJ, Ro H, Lee C, Chang JH, Lee HH, Chung W, Clarke AL, Young HM, Hull KL, Hudson N, Burton JO, Smith AC, Marx S, Petrilla A, Filipovic I, Lee WC, Meijers B, Poesen R, Storr M, Claes K, Kuypers D, Evenepoel P, Aukland M, Clarke AL, Hull KL, Burton JO, Smith AC, Betriu A, Martinez-Alonso M, Arcidiacono MV, Cannata-Andia J, Pascual J, Valdivielso JM, Fernandez-Giraldez E, Kingswood JC, Zonnenberg B, Sauter M, Zakar G, Biro B, Besenczi B, Varga A, Pekacs P, Pizzini P, Pisano A, Leonardis D, Panuccio V, Cutrupi S, Tripepi G, Mallamaci F, Zoccali C, Arnold J, Baharani J, Rayner H, So BH, Blackwell S, Jardine AG, Macgregor MS, Cunha C, Barreto P, Pereira S, Ventura A, Mota M, Seabra J, Sakaguchi T, Kobayashi S, Yano T, Yoshimoto W, Bancu I, Bonal Bastons J, Cleries Escayola M, Vela Vallespin E, Bustins Poblet M, Magem Luque D, Pastor Fabregas M, Chen JH, Chen SC, Chang JM, Hwang SJ, Chen HC, Ahbap E, Kara E, Basturk T, Sahutoglu T, Koc Y, Sakaci T, Sevinc M, Akgol C, Ozagari AA, Unsal A, Minami S, Hesaka A, Yamaguchi S, Iwahashi E, Sakai S, Fujimoto T, Sasaki K, Fujita Y, Yokoyama K, Marks A, Fluck N, Prescott G, Robertson L, Smith WC, Black C, Ohsawa M, Fujioka T, Omori S, Isurugi T, Tanno K, Onoda T, Omama S, Ishibashi Y, Makita S, Okayama A, Garland JS, Simpson CS, Metangi MF, Parfrey B, Johri AM, Sloan L, McAuley J, Cunningham R, Mullan R, Quinn M, Harron C, Chiu H, Murphy-Burke D, Werb R, Jung B, Chan-Yan C, Duncan J, Forzley B, Lowry R, Hargrove G, Carson R, Levin A, Karim M, Reznik EV, Storozhakov GIV, Rollino C, Troiano M, Bagatella M, Liuzzo C, Quarello F, Roccatello D, Blaslov K, Bulum T, Prka In I, Duvnjak L, Heleniak Z, Ciepli ska M, Szychli ski T, Pryczkowska M, Bartosi ska E, Wiatr H, Kot owska H, Tylicki L, Rutkowski B, Song YR, Kim SGK, Kim HJ, Noh JW, Tong A, Jesudason S, Craig JC, Winkelmayer WC, Hung PH, Huang YT, Hsiao CY, Sung PS, Guo HR, Tsai KJ, Wu CC, Su SL, Kao SY, Lu KC, Lin YF, Lin WH, Lee HM, Cheng MF, Wang WM, Yang LY, Wang MC, Vukovic Lela I, Sekoranja M, Poljicanin T, Karanovic S, Abramovic M, Matijevic V, Stipancic Z, Leko N, Cvitkovic A, Dika Z, Kos J, Laganovic M, Grollman AP, Jelakovic B, Dryl-Rydzynska T, Prystacki T, Malyszko J, Trifiro G, Sultana J, Giorgianni F, Ingrasciotta Y, Muscianisi M, Tari DU, Perrotta M, Buemi M, Canale V, Arcoraci V, Santoro D, Rizzo M, Iheanacho I, Van Nooten FE, Goldsmith D, Grandtnerova B, Berat ova Z, ErvenOva M, cErven J, Markech M, tefanikova A, Engelen W, Elseviers M, Gheuens E, Colson C, Muyshondt I, Daelemans R. CKD GENERAL AND CLINICAL EPIDEMIOLOGY 2. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu167] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
17
|
Testi M, Andreani M, Locatelli F, Arcese W, Troiano M, Battarra M, Gaziev J, Lucarelli G. Influence of the HLA characteristics of Italian patients on donor search outcome in unrelated hematopoietic stem cell transplantation. ACTA ACUST UNITED AC 2014; 84:198-205. [DOI: 10.1111/tan.12355] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2013] [Revised: 03/11/2014] [Accepted: 03/19/2014] [Indexed: 11/28/2022]
Affiliation(s)
- M. Testi
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - M. Andreani
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - F. Locatelli
- Department of Pediatric Hematology-Oncology, IRCCS Bambino Gesù Children's Hospital; University of Pavia; Rome Italy
| | - W. Arcese
- Rome Transplant Network, Department of Hematology, Stem Cell Transplant Unit; Tor Vergata University; Rome Italy
| | - M. Troiano
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - M. Battarra
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - J. Gaziev
- Rome Transplant Network, Department of Hematology, Stem Cell Transplant Unit; Tor Vergata University; Rome Italy
| | - G. Lucarelli
- International Center for Transplantation in Thalassemia and Sickle Cell Anemia; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| |
Collapse
|
18
|
Testi M, Battarra M, Troiano M, Testa G, Andreani M. The novel HLA-B*35:240 allele identified by sequence-based typing in an Italian family. Tissue Antigens 2014; 83:363-4. [PMID: 24646331 DOI: 10.1111/tan.12331] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/20/2014] [Accepted: 02/11/2014] [Indexed: 11/27/2022]
Affiliation(s)
- M Testi
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation at Polyclinic of Tor Vergata, Rome, Italy
| | | | | | | | | |
Collapse
|
19
|
Merola A, Zibetti M, Rizzone MG, Troiano M, Artusi CA, Angrisano S, Cocito D, Lopiano L. Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients. Acta Neurol Scand 2014; 129:e1-5. [PMID: 23834498 DOI: 10.1111/ane.12164] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/04/2013] [Indexed: 11/28/2022]
Abstract
BACKGROUND Although peripheral neuropathies (PN) have been described in patients with Parkinson's disease (PD) treated with oral dopaminergic therapies, anecdotal reports of subacute severe PN have been reported during treatment with enteral levodopa/carbidopa infusion (Duodopa). AIM OF THE STUDY We prospectively assessed clinical and electrophysiological data of 15 consecutive patients with PD treated with Duodopa for a mean follow-up of 9 months. METHODS Nerve conduction studies and a clinical evaluation with a standardized battery of peripheral neuropathy scales were performed at baseline and after a mean follow-up of 9 months. RESULTS At baseline, mild signs of PN were observed in three subjects, and vitamin B12 serum levels were found to correlate with the amplitude of sural sensory action potentials. Follow-up data were available for 10/15 subjects: one patient developed a subacute sensory-motor PN and three subjects with pre-existing PN showed a moderate worsening of electrophysiological and clinical features. Subclinical electrophysiological alterations of peripheral nerves were observed in two subjects. No significant changes were observed in vitamin B12, folate, homocysteine and methylmalonic acid levels. CONCLUSIONS In this consecutive series of patients treated with Duodopa, we observed one subacute sensory-motor PN and few length-dependent alterations of peripheral nerves, similar to those described during oral levodopa treatment.
Collapse
Affiliation(s)
- A. Merola
- Department of Neuroscience; University of Turin; Torino Italy
| | - M. Zibetti
- Department of Neuroscience; University of Turin; Torino Italy
| | - M. G. Rizzone
- Department of Neuroscience; University of Turin; Torino Italy
| | - M. Troiano
- Department of Neuroscience; University of Turin; Torino Italy
| | - C. A. Artusi
- Department of Neuroscience; University of Turin; Torino Italy
| | - S. Angrisano
- Department of Neuroscience; University of Turin; Torino Italy
| | - D. Cocito
- Department of Neuroscience; University of Turin; Torino Italy
| | - L. Lopiano
- Department of Neuroscience; University of Turin; Torino Italy
| |
Collapse
|
20
|
Testi M, Troiano M, Guagnano A, Testa G, Andreani M. A new allele,HLA-DQB1*04:09. ACTA ACUST UNITED AC 2013; 82:215-6. [DOI: 10.1111/tan.12176] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2013] [Revised: 06/18/2013] [Accepted: 07/04/2013] [Indexed: 11/30/2022]
Affiliation(s)
- M. Testi
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome; Italy
| | - M. Troiano
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome; Italy
| | - A. Guagnano
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome; Italy
| | - G. Testa
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome; Italy
| | - M. Andreani
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome; Italy
| |
Collapse
|
21
|
Cecchi R, Fancelli L, Troiano M. Island flaps in the repair of medial canthus: report of 8 cases. Dermatol Online J 2013; 19:18576. [PMID: 24011325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2013] [Accepted: 06/15/2013] [Indexed: 06/02/2023] Open
Abstract
Reconstruction of the medial canthus following skin cancer excision is often challenging because of the complex anatomy and the cosmetic relevance of that region. The island pedicle advancement flap is an extremely versatile flap, which is commonly used to close defects in different body areas, including face, trunk, and extremities. We report our favourable experience with the use of island flaps, mobilized from the nasal saddle or lateral nasal side wall in 8 patients who had skin defects on the medial canthus region after Mohs micrographic surgery for basal cell carcinomas.
Collapse
|
22
|
|
23
|
|
24
|
Sizzano F, Testi M, Zito L, Crocchiolo R, Troiano M, Mazzi B, Turchiano G, Torchio M, Pultrone C, Gregori S, Chiesa R, Gaziev J, Sodani P, Marktel S, Amoroso A, Roncarolo MG, Lucarelli G, Ciceri F, Andreani M, Fleischhauer K. Genotypes and haplotypes in the 3' untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia. ACTA ACUST UNITED AC 2012; 79:326-32. [PMID: 22489942 DOI: 10.1111/j.1399-0039.2012.01862.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Polymorphisms in the 3' untranslated region (3'UTR) of HLA-G, an important player in immunological tolerance, could be involved in post-transcriptional expression control, and their association with different clinical immune-related conditions including autoimmunity and transplantation is of mounting interest. Most studies have focused on a 14 base pair (bp) insertion/deletion (ins/del), while additional single-nucleotide polymorphisms (SNPs) in the HLA-G 3'UTR have been described but not extensively investigated for their clinical relevance. Here we have comparatively studied the association between 3'UTR haplotypes of HLA-G, or the 14 bp ins/del, with clinical outcome of HLA-identical sibling hematopoietic stem cell transplantation (HSCT) in 147 Middle Eastern beta-thalassemia patients. Sequence based typing of 3'UTR HLA-G polymorphisms in the patients and in 102 healthy Italian blood donors showed strong linkage disequilibrium between the 14 bp ins/del and five 3'UTR SNPs, which together could be arranged into eight distinct haplotypes based on expectation-maximization studies, with four predominant haplotypes (UTRs1-4). After HSCT, we found a moderate though not significant association between the presence of UTR-2 in double dose and protection from acute graft versus host disease (hazard ratio (HR) 0.45, 95% confidence intervals (CI): 0.14-1.45; P = 0.18), an effect that was also seen when the corresponding 14 bp ins/ins genotype was considered alone (HR 0.42, 95% CI: 0.16-1.06; P = 0.07). No association was found with rejection or survival. Taken together, our data show that there is no apparent added value of considering entire 3'UTR HLA-G haplotypes for risk prediction after allogeneic HSCT for beta-thalassemia.
Collapse
Affiliation(s)
- F Sizzano
- Unit of Molecular and Functional Immunogenetics, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Cecchi R, Fancelli L, Troiano M, Pavesi M. The "shark" island flap in the reconstruction of nasal ala and perialar defects. GIORN ITAL DERMAT V 2012; 147:420-422. [PMID: 23007218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
|
26
|
Campolmi P, Bonan P, Cannarozzo G, Bassi A, Bruscino N, Arunachalam M, Troiano M, Lotti T, Moretti S. Highlights of thirty-year experience of CO2 laser use at the Florence (Italy) department of dermatology. ScientificWorldJournal 2012; 2012:546528. [PMID: 22593693 PMCID: PMC3347966 DOI: 10.1100/2012/546528] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2011] [Accepted: 01/04/2012] [Indexed: 12/01/2022] Open
Abstract
The CO2 laser has been used extensively in dermatological surgery over the past 30 years and is now recognised as the gold standard for soft tissue vaporization. Considering that the continuous wave CO2 laser delivery system and the newer “superpulsed” and scanned CO2 systems have progressively changed our practice and patient satisfaction, a long range documentation can be useful. Our experience has demonstrated that the use of CO2 laser involves a reduced healing time, an infrequent need for anaesthesia, reduced thermal damage, less bleeding, less inflammation, the possibility of intra-operative histologic and/or cytologic examination, and easy access to anatomically difficult areas. Immediate side effects have been pain, erythema, edema, typically see with older methods, using higher power. The percentage of after-treatment keloids and hypertrophic scars observed was very low (~1%) especially upon the usage of lower parameters. The recurrence of viral lesions (condylomas and warts) have been not more frequent than those due to other techniques. Tumor recurrence is minor compared with radiotherapy or surgery. This method is a valid alternative to surgery and/or diathermocoagulation for microsurgery of soft tissues. Our results are at times not consistent with those published in the literature, stressing the concept that multicentric studies that harmonization methodology and the patient selection are vital.
Collapse
Affiliation(s)
- Piero Campolmi
- Section of Clinical, Preventive and Oncologic Dermatology, Department of Critical Care Medicine and Surgery, University of Florence, Villa S.Chiara, Piazza Indipendenza 11, 50129 Florence, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Testi M, Battarra M, Troiano M, Condello R, Andreani M. Characterization of the novel HLA-C*07:195 allele in an Italian hematopoietic stem cell volunteer donor, detected by sequence-based typing. ACTA ACUST UNITED AC 2012; 80:67-8. [PMID: 22443801 DOI: 10.1111/j.1399-0039.2012.01866.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The new allele shows one nucleotide change from C*07:02:01:01 at 351 nt from C to A, resulting in an amino acid change at codon 93 of exon 3 from H to Q.
Collapse
Affiliation(s)
- M Testi
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation at Polyclinic of Tor Vergata, Rome, Italy.
| | | | | | | | | |
Collapse
|
28
|
Cecchi R, Fancelli L, Troiano M. Letter: The "reading man" flap in facial reconstruction: report of 12 cases. Dermatol Online J 2012; 18:16. [PMID: 22398237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023] Open
Abstract
Reconstruction of defects in the infraorbital, malar, and temporal areas after tumor resection may present problems such as distortion of anatomic points and extra normal skin removal. The "reading man" flap is a recent local flap procedure, which has been used to solve those problems. We report our experience with this procedure, which has been used for the closure of circular defects in 12 patients (7 men and 5 women), aged 68 to 86 years (mean age: 77 years), who had undergone surgical excisions of basal cell carcinomas of the temporal, malar, and infraorbital regions. The functional and aesthetical results were satisfactory in all cases. In our experience, the "reading man" flap is a useful option for the reconstruction of circular defects in these facial areas.
Collapse
Affiliation(s)
- Roberto Cecchi
- Department of Dermatology, Spedali Riuniti, Pistoia, Italy
| | | | | |
Collapse
|
29
|
|
30
|
Massa R, Andreani M, Terracciano C, Troiano M, Marfia G, Guagnano A, Pompeo E, Piantadosi C, Testa G, Testi M. O-5
Novel HLA II associations in myasthenia gravis. ACTA MYOLOGICA 2011. [PMCID: PMC3235824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
| | - M. Andreani
- "IME" Foundation, "Tor Vergata" Policlinic, Rome, Italy
| | | | - M. Troiano
- "IME" Foundation, "Tor Vergata" Policlinic, Rome, Italy
| | | | - A. Guagnano
- "IME" Foundation, "Tor Vergata" Policlinic, Rome, Italy
| | - E. Pompeo
- Department of Surgery, "Tor Vergata" University, Rome; Neurology UOC
| | | | - G. Testa
- "IME" Foundation, "Tor Vergata" Policlinic, Rome, Italy
| | - M. Testi
- "IME" Foundation, "Tor Vergata" Policlinic, Rome, Italy
| |
Collapse
|
31
|
Testi M, Troiano M, Di Luzio A, Stellitano C, Andreani M. The novel HLA-C*06:58 allele, identified by sequence-based typing in an Italian family. ACTA ACUST UNITED AC 2011; 79:80-1. [DOI: 10.1111/j.1399-0039.2011.01751.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- M Testi
- Laboratory of Immunogenetics and Transplant Biology, Polyclinic of Tor Vergata University, Rome, Italy.
| | | | | | | | | |
Collapse
|
32
|
Prignano F, Campolmi P, Bonnan P, Ricceri F, Cannarozzo G, Troiano M, Lotti T, Prignano F, Campolmi P, Bonnan P, Ricceri F, Cannarozzo G, Troiano M, Lotti T. Fractional CO2 laser: a new therapeutic system forphotobiomodulation of skin remodeling and cytokineproduction in the course of tissue reparation. Vestnik dermatologii i venerologii 2011. [DOI: 10.25208/vdv1046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
Abstract
Eighteen female patients with the signs of photoageing underwent skin rejuvenation using a fractional CO2 laser
(SmartXide DOT, DEKA M.E.L.A., Florence, Italy) with varying energy density (2.07, 2.77 and 4.15 J/cm2). Clinical efficacy
of the said laser irradiation parameters was assessed in all of the subjects, and the skin cytokine profile was studied
by using the immunohistochemistry technique based on skin tissue samples taken prior to the treatment, right after
the treatment and in 3 and 30 days. There were significant improvements in the wrinkle and skin texture condition, and
hyperpigmentation was reduced as a result of the treatment, which proves the efficacy of using the fractional CO2 laser
for the skin photorejuvenation. The technique ensures good clinical results and is distinguished by a short rehabilitation
period and excellent safety profile. In the course of the immunohistochemistry, a relation between the skin cytokine
production, reepithelization and laser irradiation density was established.
Collapse
|
33
|
Abstract
Human leukocyte antigen (HLA) class I sequence-based typing (SBT) for hematopoietic unrelated donor searching in an Italian Caucasian patient showed the presence of a novel HLA-A allele defined as A*31:48. HLA-A*31:48 has one nucleotide change from A*31:01:02 at nt 727 from C to T, resulting in an amino acid change at codon 219 of exon 4 from Arg to Trp.
Collapse
Affiliation(s)
- M Testi
- Laboratory of Immunogenetics, IME Foundation at Polyclinic of Tor Vergata Foundation, Rome, Italy.
| | | | | | | | | |
Collapse
|
34
|
|
35
|
Abstract
Background: The penis is an unusual site of presentation for Kaposi sarcoma, especially in immunocompetent patients. Case Presentation: A 52-year-old human immunodeficiency virus (HIV)-seronegative man presented with a reddish, 8 mm in diameter nodule on the glans penis near the coronal sulcus. Histopathology after excision of the lesion was consistent with Kaposi sarcoma. No other cutaneous or mucosal manifestations were present. After a follow-up period of 2 years, no recurrence was observed. Conclusion: This unusual case suggests that Kaposi sarcoma should be considered in the differential diagnosis of macular, papular, and nodular lesions involving the penis.
Collapse
Affiliation(s)
- Roberto Cecchi
- From the Department of Dermatology, Pistoia Hospital, Pistoia, Italy
| | - Michela Troiano
- From the Department of Dermatology, Pistoia Hospital, Pistoia, Italy
| | - Maurizia Ghilardi
- From the Department of Dermatology, Pistoia Hospital, Pistoia, Italy
| | - Laura Bartoli
- From the Department of Dermatology, Pistoia Hospital, Pistoia, Italy
| |
Collapse
|
36
|
Testi M, Lai S, Orrù S, Alba F, Cappai L, Firdous N, Gaziev J, Troiano M, Andreani M, Carcassi C. Distribution of HLA alleles and haplotypes in the Maldivian population. ACTA ACUST UNITED AC 2011; 77:235-8. [DOI: 10.1111/j.1399-0039.2010.01598.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
37
|
Campolmi P, Bonan P, Cannarozzo G, Bruscino N, Troiano M, Prignano F, Lotti T. Intense pulsed light in the treatment of non-aesthetic facial and neck vascular lesions: report of 85 cases. J Eur Acad Dermatol Venereol 2010; 25:68-73. [PMID: 20477927 DOI: 10.1111/j.1468-3083.2010.03700.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- P Campolmi
- Department of Dermatology II, University of Florence, Florence, Italy
| | | | | | | | | | | | | |
Collapse
|
38
|
Morelli F, Troiano M, Mastrodonato N, Di Maggio G, Nanni L, Lombardi L, Parisi S, Di Sebastiano P, Maiello E. 10 CHEMORADIATION THERAPY FOR CARCINOMA OF THE ANAL CANAL. Cancer Treat Rev 2010. [DOI: 10.1016/s0305-7372(10)70036-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
39
|
Cecchi R, Troiano M, Buralli L, Innocenti S. Recurrent distal digital keratoacanthoma of the periungual region treated with Mohs micrographic surgery. Australas J Dermatol 2010; 53:e5-7. [DOI: 10.1111/j.1440-0960.2010.00692.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
Abstract
BACKGROUND Nail psoriasis occurs in up to half of psoriatic patients and can lead to significant physical impairment and pain. To date, patients and clinicians are actually dissatisfied by current therapeutic approaches. OBJECTIVE Our main aim is to evaluate Infliximab efficacy in nail psoriasis. METHODS We performed an open-label and uncontrolled retrospective study considering all psoriatic patients presenting recalcitrant nail involvement and receiving Infliximab in our Department during the period between January 2008 and March 2009. We calculated nail psoriasis severity index (NAPSI) score at 0, 14, 22 and 38 weeks and percentage of patients achieving NAPSI-50,-75,-90 at 14, 22 and 38 weeks. RESULTS We observed a rapid nail improvement in most cases after 22 weeks of Infliximab therapy, but a complete nail clearing was reached in only five (10.4%) patients. We don't have a follow-up longer than 38 weeks to assess long-term efficacy of this treatment in nail psoriasis. CONCLUSIONS Infliximab, in our experience, has proved to be effective in reducing nail lesions and, in some cases, even clearing them. Our data demonstrate long-term efficacy of this biological agent in nail psoriasis.
Collapse
Affiliation(s)
- C Fabroni
- University of Florence, Via Lorenzo il Magnifico, Florence, Italy.
| | | | | | | | | |
Collapse
|
41
|
|
42
|
Prignano F, Campolmi P, Bonan P, Ricceri F, Cannarozzo G, Troiano M, Lotti T. Fractional CO2laser: a novel therapeutic device upon photobiomodulation of tissue remodeling and cytokine pathway of tissue repair. Dermatol Ther 2009; 22 Suppl 1:S8-15. [DOI: 10.1111/j.1529-8019.2009.01265.x] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
43
|
Prignano F, Ricceri F, Pescitelli L, Buggiani G, Troiano M, Zanieri F, Rossari S, Lotti T. Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. Curr Med Res Opin 2009; 25:2311-6. [PMID: 19635043 DOI: 10.1185/03007990903162465] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVE This study is a retrospective analysis evaluating the presence of comorbidities, as well as the changes in body weight and clinical parameters in psoriasis patients following treatment with anti-TNF-alpha agents and with the anti-CD11a agent efalizumab. RESEARCH DESIGN AND METHODS A total of 268 patients affected by chronic plaque psoriasis, and receiving systemic monotherapy with efalizumab, etanercept, or infliximab, were included. The follow-up period was 2, 4 and 6 months. MAIN OUTCOME MEASURES Clinical data including age, gender, weight, type and severity of psoriasis and age of onset were collected. Severity of psoriasis was assessed according to the Psoriasis Area and Severity Index (PASI) and body surface area (BSA). RESULTS Hypertension and hyperlipidaemia were the comorbidities present with the higher frequency in our group of patients. PASI score was reduced by between 43.8 and 52% in all treatment groups. No relevant blood chemistry changes were observed following therapy, with the exception of a decrease in neutrophils and an increase in leukocyte numbers reported in the efalizumab and etanercept groups. Interestingly, after 6 months of therapy, the weight of the patients remained unvaried in those taking efalizumab (-0.05%) but was moderately increased in the etanercept (+0.72%) and in infliximab groups (+0.3%). CONCLUSIONS The present study shows that there were clinically significant differences in weight gain effects between efalizumab and anti-TNF-alpha agents in psoriatic patients. The changes in body weight gain increase did not reach statistical significance, although there is a trend towards this, and this may be due to the relatively small number of patient studied.
Collapse
Affiliation(s)
- F Prignano
- Department of Dermatological Sciences, Physiotherapy Unit, Firenze, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Troiano M, Lotti T. Rituximab in dermatological diseases. GIORN ITAL DERMAT V 2009; 144:495-499. [PMID: 19755955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Rituximab is a chimeric monoclonal antibody currently used for the treatment of non-Hodgkin lymphoma that targets the transmembrane protein CD20 of B cells. Recently it has also been used for the treatment of several autoimmune diseases, including skin disorders such as Paraneoplastic Pemphigus, Pemphigus Vulgaris, Pemphigus Foliaceus, Mucosal pemphigoid, Bullous pemphigoid, Epidermolysis bullosa acquisita, Systemic lupus erythematous and Dermatomyositis. Frequently all these conditions required intolerably high doses of corticosteroids and additional immunosoppressants, which can increase the risk of severe adverse events. Therefore, new therapeutic options are needed for such patients. The intent of the authors in this review is to provide the reader with a panoramic view of the studies reported to date.
Collapse
Affiliation(s)
- M Troiano
- Second Dermatologic Clinic, University of Florence, Florence, Italy
| | | |
Collapse
|
45
|
Abstract
New allele B*0769 showed one nucleotide difference with B*0732 at codon 272 (TTC-->TGC).
Collapse
Affiliation(s)
- M Testi
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation, Polyclinic of Tor Vergata University, Rome, Italy.
| | | | | | | | | |
Collapse
|
46
|
Troiano M, Corsa P, Raguso A, Cossa S, Piombino M, Guglielmi G, Parisi S. Radiation therapy in urinary cancer: state of the art and perspective. Radiol Med 2008; 114:70-82. [PMID: 19082788 DOI: 10.1007/s11547-008-0347-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2008] [Accepted: 04/10/2008] [Indexed: 12/19/2022]
Abstract
Invasive urinary tumours are relatively rare, and their treatment may cause important changes in urinary, sexual and social functions. A systematic review of external radiation therapy studies in urinary cancers was performed. This synthesis of the literature is based on data from meta-analyses, randomised and prospective trials and retrospective studies. There are few controlled clinical trials using adjuvant or radical radiotherapy with or without chemotherapy in cancer of the kidney, ureter and urethra. There are several reports on multimodality treatment in invasive bladder cancer: intravesical surgery and neoadjuvant chemotherapy to radiotherapy or concomitant radiochemotherapy with organ preservation. The conclusions reached for renal cancer are controversial, and data on cancers of the urethra and ureter are few and inconclusive. Sufficient data now exist in the literature to demonstrate that conservative management with organ preservation is a valuable alternative to radical cystectomy, the traditional gold standard, in invasive bladder cancer.
Collapse
Affiliation(s)
- M Troiano
- Department of Radiation Oncology, Scientific Institute Hospital Casa Sollievo della Sofferenza, and University of Foggia, Department of Radiology, San Giovanni Rotondo, 71013, Foggia, Italy
| | | | | | | | | | | | | |
Collapse
|
47
|
Morelli F, Raguso A, Piano A, Troiano M, Palomba G, Nanni L, Di Bisceglie M, Parisi S, Maiello E. Radiochemotherapy for anal carcinoma: Our experience. EJC Suppl 2008. [DOI: 10.1016/j.ejcsup.2008.06.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
48
|
Campolmi P, Troiano M, Bonan P, Cannarozzo G, Lotti T. Vascular based non conventional dye laser treatment for basal cell carcinoma. Dermatol Ther 2008; 21:402-5. [DOI: 10.1111/j.1529-8019.2008.00221.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Lotti T, Buggiani G, Troiano M, Assad GB, Delescluse J, De Giorgi V, Hercogova J. Targeted and combination treatments for vitiligo
Comparative evaluation of different current modalities in 458 subjects. Dermatol Ther 2008; 21:S20-S26. [DOI: 10.1111/j.1529-8019.2008.00198.x] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023]
|
50
|
Buggiani G, Troiano M, Rossi R, Lotti T. Photodynamic therapy: Off-label and alternative use in dermatological practice. Photodiagnosis Photodyn Ther 2008; 5:134-8. [DOI: 10.1016/j.pdpdt.2008.03.001] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2008] [Revised: 03/18/2008] [Accepted: 03/21/2008] [Indexed: 10/22/2022]
|